Cannara Biotech Inc.
LOVE.V
TSX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 75.55% | 100.52% | 182.88% | 109.88% | -28.60% |
| Total Depreciation and Amortization | 4.05% | 2.78% | 2.25% | 11.34% | 15.68% |
| Total Amortization of Deferred Charges | -52.37% | -68.80% | 22.97% | 22.97% | 8.28% |
| Total Other Non-Cash Items | 1,349.99% | 3,069.27% | -92.30% | -187.95% | 317.76% |
| Change in Net Operating Assets | -387.03% | -185.13% | 51.93% | 14.05% | 128.94% |
| Cash from Operations | 34.49% | 77.18% | 84.08% | 19.35% | 141.19% |
| Capital Expenditure | -60.64% | 17.09% | 40.57% | 25.68% | 33.47% |
| Sale of Property, Plant, and Equipment | -92.69% | -92.56% | -98.66% | 1,618.27% | 1,080.82% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.21% | 47.97% | 23.59% | 20.39% | -9.64% |
| Cash from Investing | -150.18% | -11.59% | 22.12% | 51.79% | 57.40% |
| Total Debt Issued | -100.00% | -91.23% | -93.06% | -58.46% | -32.73% |
| Total Debt Repaid | 33.86% | 33.94% | 35.00% | -98.67% | -115.95% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | 100.00% | 99.34% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 10.48% | 12.54% | 25.13% | 42.57% | 21.93% |
| Cash from Financing | -31.20% | -74.75% | -104.91% | -135.73% | -114.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.76% | 225.64% | 510.47% | 314.47% | 283.40% |